Literature DB >> 8526150

Functional CD40 antigen on B cells, dendritic cells and fibroblasts.

J Banchereau1, B Dubois, J Fayette, N Burdin, F Brière, P Miossec, M C Rissoan, C van Kooten, C Caux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8526150     DOI： 10.1007/978-1-4615-1971-3_16

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  14 in total

Review 1.  Molecular mechanism and function of CD40/CD40L engagement in the immune system.

Authors:  Raul Elgueta; Micah J Benson; Victor C de Vries; Anna Wasiuk; Yanxia Guo; Randolph J Noelle
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

2.  Murine Fibroblastic Reticular Cells From Lymph Node Interact With CD4+ T Cells Through CD40-CD40L.

Authors:  Yumi Nakayama; C Colin Brinkman; Jonathan S Bromberg
Journal:  Transplantation       Date:  2015-08       Impact factor: 4.939

3.  Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation.

Authors:  Aaron J Martin; Derrick McCarthy; Carl Waltenbaugh; Gwen Goings; Xunrong Luo; Stephen D Miller
Journal:  J Immunol       Date:  2010-08-16       Impact factor: 5.422

4.  Macrophage effector responses of horses are influenced by expression of CD154.

Authors:  Brett A Sponseller; Sandra K Clark; Jessica Gilbertie; David M Wong; Kate Hepworth; Sarah Wiechert; Prashanth Chandramani; Beatrice T Sponseller; Cody J Alcott; Bryan Bellaire; Andrew C Petersen; Douglas E Jones
Journal:  Vet Immunol Immunopathol       Date:  2016-08-26       Impact factor: 2.046

5.  CD28 and inducible costimulator (ICOS) signalling can sustain CD154 expression on activated T cells.

Authors:  Denise A Kaminski; Byung O Lee; Sheri M Eaton; Laura Haynes; Troy D Randall
Journal:  Immunology       Date:  2008-12-13       Impact factor: 7.397

Review 6.  Targeting costimulatory molecules to improve antitumor immunity.

Authors:  Daria Capece; Daniela Verzella; Mariafausta Fischietti; Francesca Zazzeroni; Edoardo Alesse
Journal:  J Biomed Biotechnol       Date:  2012-02-12

7.  Lineage-restricted function of nuclear factor kappaB-inducing kinase (NIK) in transducing signals via CD40.

Authors:  N Garceau; Y Kosaka; S Masters; J Hambor; R Shinkura; T Honjo; R J Noelle
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

8.  Characterization of a Broadly Reactive Anti-CD40 Agonistic Monoclonal Antibody for Potential Use as an Adjuvant.

Authors:  Cameron Martin; Suryakant D Waghela; Shehnaz Lokhandwala; Andy Ambrus; Jocelyn Bray; Christina Vuong; Vanitha Vinodkumar; Paul J Dominowski; Sharath Rai; Duncan Mwangi; Dennis L Foss; Waithaka Mwangi
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

9.  C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer.

Authors:  Kosuke Sasaki; Shigetsugu Takano; Satoshi Tomizawa; Yoji Miyahara; Katsunori Furukawa; Tsukasa Takayashiki; Satoshi Kuboki; Mamoru Takada; Masayuki Ohtsuka
Journal:  J Exp Clin Cancer Res       Date:  2021-06-24

10.  The biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: reciprocal regulation by interleukin (IL)-4 and IL-12.

Authors:  Byung O Lee; Laura Haynes; Sheri M Eaton; Susan L Swain; Troy D Randall
Journal:  J Exp Med       Date:  2002-09-02       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.